| Literature DB >> 28327539 |
Chenkang Zheng1, Katherine A Black2, Patricia C Dos Santos3.
Abstract
Sulfur-containing transfer ribonucleic acids (tRNAs) are ubiquitous biomolecules found in all organisms that possess a variety of functions. For decades, their roles in processes such as translation, structural stability, and cellular protection have been elucidated and appreciated. These thionucleosides are found in all types of bacteria; however, their biosynthetic pathways are distinct among different groups of bacteria. Considering that many of the thio-tRNA biosynthetic enzymes are absent in Gram-positive bacteria, recent studies have addressed how sulfur trafficking is regulated in these prokaryotic species. Interestingly, a novel proposal has been given for interplay among thionucleosides and the biosynthesis of other thiocofactors, through participation of shared-enzyme intermediates, the functions of which are impacted by the availability of substrate as well as metabolic demand of thiocofactors. This review describes the occurrence of thio-modifications in bacterial tRNA and current methods for detection of these modifications that have enabled studies on the biosynthesis and functions of S-containing tRNA across bacteria. It provides insight into potential modes of regulation and potential evolutionary events responsible for divergence in sulfur metabolism among prokaryotes.Entities:
Keywords: 2-methylthioadenosine; 2-thiouridine; 4-thiouridine; cysteine desulfurases; tRNA; thiocofactor; thionucleoside; thiouridylase
Mesh:
Substances:
Year: 2017 PMID: 28327539 PMCID: PMC5372745 DOI: 10.3390/biom7010033
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Location of thio-modifications in transfer ribonucleic acid (tRNA). The structure of a tRNAGln transcript (4jxz) with the positions of modified thionucleotides (red) was obtained in complex with Escherichia coli glutaminyl-tRNA synthetase (GlnRS) (not shown). The tRNA backbone and other nucleotides are colored by regions within which they are located on the tRNA as follows: The conserved CCA sequence to which amino acids are attached at the 3′ end is shown in navy, acceptor stem in royal blue, the D-loop in cyan, the anticodon loop in green, and the T-loop in periwinkle. It is important to note that in this isoacceptor, only positions 34 and 37 carry thionucleotides, and that this figure means to represent the locations of such modifications within a tRNA tertiary structure, rather than accurate information about a specific isoacceptor.
Figure 2Structures of bacterial tRNA thionucleosides and their derivatives. The structures of the thionucleosides occurring in bacterial tRNA at positions 8, 32, 34, 37 and 54 are shown along with their hypermodified derivatives, with the sulfur atom highlighted in yellow. The structures of 2-geranylthiouridine (ges2U) and 2-selenouridine (se2U), whose biosynthesis relies on U34 thiolation, as described in Table 1, are also depicted along with their derivatives. mnm5s2U, cmnm5s2U, and inm5s2U may be methylated at 2′ OH. The cyclic form of t6A37 was first hypothesized to exist in the oxazolone isoform, however, further investigation has revealed that it actually exists in the hydantoin isoform.
Bacterial tRNA modifications whose biosynthesis relies on sulfur mobilization.
| Fe-S Cluster Independent Modifications | ||||
|---|---|---|---|---|
| Modification | Name | Position | Biosynthetic Genes and Precursors | |
| s4U | 4-thiouridine | 8 | ||
| s2U | 2-thiouridine | 34 | ||
| mnm5s2U | 5-methylaminomethyl-2-thiouridine | 34 | s2U, | |
| cmnm5s2U | 5-carboxymethylaminomethyl-2-thiouridine | 34 | s2U, | |
| inm5s2U | 5-(isopentenylaminomethyl)-2-thiouridine | 34 | nm5s2U, unknown isopentenyltransferase ( | |
| nm5s2U | 5-aminomethyl-2-thiouridine | 34 | s2U, | |
| se2U | 2-selenouridine | 34 | s2U, | |
| mnm5se2U | 5-methylaminomethyl-2-selenouridine | 34 | mnm5s2U, | |
| ges2U | 2-geranylthiouridine | 34 | s2U, | |
| cmnm5ges2U | 5-carboxymethylaminomethyl-2-geranylthiouridine | 34 | cmnm5s2U, | |
| mnm5ges2U | 5-methylaminomethy-2-geranylthiouridine | 34 | mnm5s2U, | |
| nm5ges2U | 5-aminomethyl-2-geranylthiouridine | 34 | nm5s2U, proposed | |
| ct6A | cyclic | 37 | t6A | |
| m5s2U/s2T | 5-methyl-2-thiouridine/2-thioribothymidine | 54 | ||
|
| ||||
|
|
|
|
| |
| s2C | 2-thiocytidine | 32 | ||
| Q | queuosine | 34 | ||
| m2A | 2-methyladenosine | 37 | ||
| ms2i6A | 2-methylthio- | 37 | i6A, | |
| ms2io6A | 2-methylthio- | 37 | ms2i6A, | |
| ms2t6A | 2-methylthio- | 37 | t6A, | |
| ms2ct6A | 2-methylthio-cyclic- | 37 | ms2t6A, | |
General methods for detection and analysis of tRNA modifications.
| Method | Target Modification | Advantage | Disadvantage |
|---|---|---|---|
| Chemical labeling | s2U, s4U, mnm5s2U, pseudouridine | Labeling only occurs in the modified species; high selectivity | Detection method varies with modification and potential side reactions |
| Northern Blot | all | High sensitivity towards specific tRNA sequences | Unable to differentiate modified and canonical nucleotides; requires RNA probe for each cognate tRNA; may require radioactive probe |
| Immuno-Northern Blot | m1A, m6A, m5C | Antibodies bind specifically to the modified nucleoside | Limited antibodies |
| APM-gel | s4U, s2U and derivatives | Detect polynucleotides and single nucleosides; simple analysis | Hazardous mercury compound involved; varied sensitivity toward different thionucleotides |
| APB-gel | Q | Specific to Q modification | Reactive with |
| HPLC-UV/vis | all | Simple sample preparation and data quantification. Certain nucleosides have unique absorbance λ max | Nuclease and phosphatase treatments |
| HPLC-MS | all | High sensitivity and accuracy | Detection may result of fragmentation of certain modifications |
APB: N-acryloyl-3-aminophenylboronic acid; APM: [(N-acryloylamino)phenyl]mercuric chloride; HPLC-UV: High Pressure Liquid Chromatography separation coupled to ultraviolet detection; HPLC-MS: High Pressure Liquid Chromatography separation coupled to Mass Spectrometry detection.
Molecular masses of tRNA modifications dependent on sulfur metabolism and standards.
| S-Dependent Modifications | |||||
|---|---|---|---|---|---|
| Modification | Name | Monoisotopic Mass (amu) | Observed Molecular Ion ( | Major Fragment ( | Standard ** |
| s2C | 2-thiocytidine | 259.063 | 260.071 | 128.028 | 1 |
| s2U | 2-thiouridine | 260.047 | 261.055 | 129.009 * | 1 |
| s4U | 4-thiouridine | 260.047 | 261.055 | 129.009 * | 2 |
| s2Um | 2-thio-2′- | 274.062 | 275.067 | 129.008 * | |
| m5s2U/s2T | 5-methyl-2-thiouridine/2-thioribothymidine | 274.062 | 275.062 | 143.019 | 1, 2 |
| m2A † | 281.112 | 282.114 | 150.071 | ||
| nm5s2U | 5-methylaminomethyl-2-thiouridine | 289.073 | 290.081 | 158.038 | |
| mnm5s2U | 5-methylaminomethyl-2-thiouridine | 303.089 | 304.097 | 172.057 * | |
| se2U | 2-selenouridine | 305.992 | 306.999 | 174.956 | |
| ms2m6A | 2-methylthio- | 327.100 | 328.108 | 196.065 | |
| cmnm5s2U | 5-carboxymethylaminomethyl-2-thiouridine | 347.079 | 348.082 | 216.047 * | |
| mnm5se2U | 5-methylaminomethyl-2-selenouridine | 349.034 | 350.034 | 217.991 | |
| inm5s2U | 5-(isopentenylaminomethyl)-2-thiouridine | 357.136 | 358.144 | 226.101 | |
| ms2i6A | 2-methylthio- | 381.147 | 382.155 | 250.108 * | 1 |
| cmnm5se2U | 5-carboxymethylaminomethyl-2-selenouridine | 393.024 | 394.032 | 261.989 | |
| ct6A | cyclic | 394.124 | 395.128 | 263.089 * | |
| ges2U | 2-geranylthiouridine | 396.172 | 397.180 | 265.137 | |
| ms2io6A | 2-methylthio- | 397.142 | 398.150 | 266.107 | |
| Q | queuosine | 409.160 | 410.168 | 278.125 | |
| nm5ges2U | 5-methylaminomethyl-2-geranylthiouridine | 425.198 | 426.206 | 294.163 | |
| mnm5ges2U | 5-methylaminomethyl-2-geranylthiouridine | 439.214 | 440.222 | 308.179 | |
| ms2ct6A | 2-methylthio-cyclic- | 440.111 | 441.119 | 309.076 | |
| ms2t6A | 2-methylthio- | 458.112 | 459.130 | 182.049 * | |
| ms2hn6A | 2-methylthio- | 472.138 | 473.146 | 341.103 | |
| cmnm5ges2U | 5-carboxymethylaminomethyl-2-geranylthiouridine | 483.204 | 484.212 | 352.169 | |
|
| |||||
|
|
|
|
|
|
|
| cmnm5Um | 5-carboxymethylaminomethyl-2′- | 345.117 | 346.117 | 200.058 * | |
| m6A | 281.112 | 282.114 | 150.071 * | 1 | |
| mnm5U | 5-methylaminomethyluridine | 287.112 | 288.120 | 156.074 * | |
| i6A | 335.159 | 336.167 | 204.119 * | 1 | |
| inm5U | 5-(isopentenylaminomethyl) uridine | 341.159 | 342.167 | 210.135 | |
| io6A | 351.154 | 352.156 | 220.115 * | ||
| inm5Um | 5-(isopentenylaminomethyl)-2′- | 355.174 | 356.182 | 224.139 | |
| t6A | 412.134 | 413.142 | 136.062 * | 3 | |
| oQ | epoxyqueuosine | 425.155 | 426.163 | 294.120 | |
| hn6A | 426.150 | 427.158 | 295.115 | ||
|
| |||||
|
|
|
|
|
|
|
| I | Inosine ‡ | 268.081 | 269.088 | 137.047 * | 2 |
| Ψ | Pseudouridine † | 244.070 | 245.078 | 209.052 * | 2 |
| D | Dihydrouridine † | 246.085 | 247.092 | 115.050 * | 4, 5 |
* major fragment masses have been experimentally validated [151]; ** commercially available standards: 1-Carbosynth Ltd., Berkshire, United Kingdom, 2-Sigma-Aldrich, St Louis, MO, USA, 3-BioLog Life Science Institute, Bremen, Germany, 4-Advanced Technology & Industrial Co., Ltd., Hong Kong, China, 5-Dalton Pharma Services, Toronto, Canada; † Also found in bacterial ribosomal RNA; ‡ Has not been found in bacterial messenger RNA, but occurs in eukaryotic mRNA.
Figure 3Proposed mechanism for thiolation of tRNA U8 by E. coli IscS and ThiI (adapted from [64,162]). The ThiI thiouridylase domain (dark blue) catalyzes the ATP-dependent adenylation of C4 of uridine and release of pyrophosphate (PPi) (1). IscS promotes persulfide sulfur transfer to Cys456 of ThiI’s rhodanese-like domain (light blue) (2). In one of the proposed mechanisms, the persulfide sulfur then conducts a nucleophilic attack onto the activated C4 of U8 tRNA (3), which leads to release of the leaving group AMP (4). The reaction is then resolved through formation of a disulfide bond between Cys456 and Cys344 and release of the product s4U tRNA (5). Regeneration of the enzyme for subsequent catalytic cycles requires the involvement of a yet unidentified reductase (5). An alternative proposal for the formation of s4U involves the local formation of sulfide at the enzyme active site which then directly attacks the adenylated intermediate (not shown). In both models, the reaction cycle is marked by the release of AMP and the s4U tRNA product along with the formation of a disulfide bond between Cys344 and Cys456.
Figure 4E. coli MnmA in complex with tRNAGlu. The structure of the E. coli 2-thiouridine biosynthetic enzyme MnmA is shown in complex with tRNAGlu (gray) in the initial tRNA binding form (2DER, left) and the tRNA adenylated intermediate form (2DEU, right). E. coli MnmA is colored by domain; the N-terminal catalytic domain (residues 4–215) is shown in green, while the central domain (residues 216–277), variable segment (residues 187–215) and the C-terminal domain (residues 278–368) are shown in cyan, purple and blue, respectively. U34 is shown in red and AMP is displayed in in orange. The sulfur atoms of the MnmA catalytic Cys residues, 102 and 199, are shown in yellow. C-term: C-terminal and N-term: N-terminal.
Figure 5Proposed mechanism for methylthiolation of tRNA A37 by MiaB and MtaB. In the first step of the mechanism (1), a methyl group (in blue) is transferred from S-adenosylmethionine (SAM) to a sulfide ion (in yellow) previously ligated to the free Fe on the auxiliary [4Fe-4S] cluster. In steps 2 and 3, the radical SAM [4Fe-4S] cluster, via its free Fe, binds a second SAM molecule, which subsequently undergoes reductive cleavage, releasing methionine and the 5′-deoxyadenosyl radical (5′-dAdo•, in red). Next (4), the highly reactive 5′-dAdo• abstracts a H from C2 of tRNA r6A37 (previously modified at the C6 position), generating a r6A37• radical at C2 and releasing 5′-deoxyadenosine (5′-dAdo). In the final step (5), the r6A37• radical facilitates transfer of the methylthio group from the auxiliary 4Fe-4S to C2 of r6A37, yielding the final ms2r6A37 product. In this legend, “free Fe” refers to the only Fe within the cluster not ligated to a Cys residue within the enzyme.